Targeting NRF2 uncovered an intrinsic susceptibility of acute myeloid leukemia cells to ferroptosis.

Authors:
Liu X; Zhong S; Qiu K; Chen X; Wu W and 11 more

Journal:
Exp Hematol Oncol

Publication Year: 2023

DOI:
10.1186/s40164-023-00411-4

PMCID:
PMC10189915

PMID:
37198609

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThis study was approved by the ethics committee of the affiliated hospitals of Jinan University. Written informed consent was obtained from all patients. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This study was supported by grants from the National Natural Science Foundation of China (Nos. 81770158, 32000802 and 81890991), Guangdong Basic and Applied Basic Research Foundation (No. 2023A1515012118), and National Innovation and Entrepreneurship Training Program for Undergraduate (Nos. 202110559101 and 202210559061)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025